• Publications
  • Influence
Guidelines for the use and interpretation of assays for monitoring autophagy
In 2008 we published the first set of guidelines for standardizing research in autophagy. Since then, research on this topic has continued to accelerate, and many new scientists have entered theExpand
  • 5,693
  • 454
  • PDF
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass.
INTRODUCTION Patients diagnosed with epithelial ovarian cancer (EOC) have improved outcomes when cared for at centers experienced in the management of EOC. The objective of this trial was to validateExpand
  • 606
  • 61
The biology of ovarian cancer: new opportunities for translation
Over the past two decades, the 5-year survival for ovarian cancer patients has substantially improved owing to more effective surgery and treatment with empirically optimized combinations ofExpand
  • 1,139
  • 59
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.
PURPOSE To update the recommendations for the use of tumor marker tests in the prevention, screening, treatment, and surveillance of gastrointestinal cancers. METHODS For the 2006 update, an updateExpand
  • 1,263
  • 55
Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A.
Glycogen synthase kinase 3 (GSK-3) is implicated in multiple biological processes including metabolism, gene expression, cell fate determination, proliferation, and survival. GSK-3 activity isExpand
  • 679
  • 51
  • PDF
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
In 2008 we published the first set of guidelines for standardizing research in autophagy. Since then, research on this topic has continued to accelerate, and many new scientists have entered theExpand
  • 2,916
  • 44
  • PDF
Rethinking ovarian cancer: recommendations for improving outcomes
There have been major advances in our understanding of the cellular and molecular biology of the human malignancies that are collectively referred to as ovarian cancer. At a recent Helene HarrisExpand
  • 959
  • 43
  • PDF
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.
PURPOSE To update the recommendations for the use of tumor marker tests in the prevention, screening, treatment, and surveillance of breast cancer. METHODS For the 2007 update, an Update CommitteeExpand
  • 1,384
  • 41
  • PDF
The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.
OBJECTIVES The CA125 tumor marker is used to help predict the presence of ovarian cancer in patients with an adnexal mass. Because elevated CA125 levels occur in many benign gynecologic conditions,Expand
  • 574
  • 40
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer.
Purpose To update the recommendations for the use of tumor marker tests in the prevention, screening, treatment, and surveillance of breast cancer. Methods For the 2007 update, an Update CommitteeExpand
  • 751
  • 32
  • PDF
...
1
2
3
4
5
...